SWS
RPRX icon

SYSTM Wealth Solutions’s Royalty Pharma RPRX Stock Holding History

SYSTM Wealth Solutions’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,836
Closed -$997K – 916
2024
Q1 		$997K Buy
32,836
+23,373
+247% +$689K 0.13% 202
2023
Q4 		$266K Buy
+9,463
New +$260K 0.04% 344

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SYSTM Wealth Solutions's RPRX Position: Q2 2024 in Review

SYSTM Wealth Solutions sold out of Royalty Pharma (RPRX) in Q2 2024, closing a stake of 32,836 shares — an estimated $997K sold.

SYSTM Wealth Solutions first reported a position in RPRX in Q4 2023 and held it in 2 quarters. The position peaked at $997K in Q1 2024. 378 funds tracked by Wall St. Rank hold RPRX as of Q2 2024.

  • SYSTM Wealth Solutions reported no remaining Royalty Pharma position as of Q2 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 32,836 Royalty Pharma shares in Q2 2024, an estimated $997K.
  • SYSTM Wealth Solutions first reported a position in Royalty Pharma in Q4 2023 and held it in 2 quarters.
  • SYSTM Wealth Solutions's Royalty Pharma position peaked at $997K in Q1 2024.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q2 2024, filed 12 Aug 2024.